RecruitingNCT05750706

Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Prospective Observational Study on Incidence of Invasive Fungal Infections Among Patients With Acute Lymphoblastic Leukemia Ph-negative

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Enrollment

150 participants

Start Date

Jun 1, 2022

Study Type

OBSERVATIONAL

Conditions

Invasive Fungal Infections Acute Lymphoblastic Leukemia, Adult

Summary

The study aims to evaluate incidence of invasive antifungal infections among patients with acute lymphoblastic leukemia Ph negative during the first weeks of treatment

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is tracking how often adults with a specific type of leukemia — Philadelphia chromosome-negative acute lymphoblastic leukemia (ALL) — develop serious fungal infections during treatment. This information will help guide better prevention and treatment strategies. **You may be eligible if...** - You are over 18 years old - You have been newly diagnosed with Philadelphia chromosome-negative (Ph-negative) acute lymphoblastic leukemia **You may NOT be eligible if...** - Your leukemia is Philadelphia chromosome-positive (Ph+) - Your leukemia has relapsed or is refractory (no longer responding to treatment) - You have lymphoblastic lymphoma (a related but different diagnosis) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.